These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1270 related articles for article (PubMed ID: 25700755)

  • 1. Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial.
    Osnabrugge RL; Arnold SV; Reynolds MR; Magnuson EA; Wang K; Gaudiani VA; Stoler RC; Burdon TA; Kleiman N; Reardon MJ; Adams DH; Popma JJ; Cohen DJ;
    JACC Cardiovasc Interv; 2015 Feb; 8(2):315-323. PubMed ID: 25700755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.
    Arnold SV; Reynolds MR; Wang K; Magnuson EA; Baron SJ; Chinnakondepalli KM; Reardon MJ; Tadros PN; Zorn GL; Maini B; Mumtaz MA; Brown JM; Kipperman RM; Adams DH; Popma JJ; Cohen DJ;
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1207-1217. PubMed ID: 26292584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.
    Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ;
    JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial.
    Baron SJ; Arnold SV; Reynolds MR; Wang K; Deeb M; Reardon MJ; Hermiller J; Yakubov SJ; Adams DH; Popma JJ; Cohen DJ;
    Am Heart J; 2017 Dec; 194():39-48. PubMed ID: 29223434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease.
    Crestanello JA; Popma JJ; Adams DH; Deeb GM; Mumtaz M; George B; Huang J; Reardon MJ
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2283-2293. PubMed ID: 29102579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry.
    Arnold SV; Spertus JA; Vemulapalli S; Li Z; Matsouaka RA; Baron SJ; Vora AN; Mack MJ; Reynolds MR; Rumsfeld JS; Cohen DJ
    JAMA Cardiol; 2017 Apr; 2(4):409-416. PubMed ID: 28146260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.
    Baron SJ; Magnuson EA; Lu M; Wang K; Chinnakondepalli K; Mack M; Thourani VH; Kodali S; Makkar R; Herrmann HC; Kapadia S; Babaliaros V; Williams MR; Kereiakes D; Zajarias A; Alu MC; Webb JG; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2019 Dec; 74(23):2833-2842. PubMed ID: 31577923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-Year Health Status After Self-expanding Transcatheter or Surgical Aortic Valve Replacement in High-risk Patients With Severe Aortic Stenosis.
    Arnold SV; Chinnakondepalli KM; Magnuson EA; Reardon MJ; Deeb GM; Gleason T; Yakubov SJ; Cohen DJ;
    JAMA Cardiol; 2021 Jan; 6(1):97-101. PubMed ID: 32997095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
    Popma JJ; Adams DH; Reardon MJ; Yakubov SJ; Kleiman NS; Heimansohn D; Hermiller J; Hughes GC; Harrison JK; Coselli J; Diez J; Kafi A; Schreiber T; Gleason TG; Conte J; Buchbinder M; Deeb GM; Carabello B; Serruys PW; Chenoweth S; Oh JK;
    J Am Coll Cardiol; 2014 May; 63(19):1972-81. PubMed ID: 24657695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A).
    Reynolds MR; Magnuson EA; Wang K; Thourani VH; Williams M; Zajarias A; Rihal CS; Brown DL; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2012 Aug; 60(6):548-58. PubMed ID: 22818074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.
    Kleiman NS; Van Mieghem NM; Reardon MJ; Gada H; Mumtaz M; Olsen PS; Heiser J; Merhi W; Chetcuti S; Deeb GM; Chawla A; Kiaii B; Teefy P; Chu MWA; Yakubov SJ; Windecker S; Althouse AD; Baron SJ
    JACC Cardiovasc Interv; 2024 Apr; 17(8):979-988. PubMed ID: 38658126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis.
    Reynolds MR; Magnuson EA; Lei Y; Leon MB; Smith CR; Svensson LG; Webb JG; Babaliaros VC; Bowers BS; Fearon WF; Herrmann HC; Kapadia S; Kodali SK; Makkar RR; Pichard AD; Cohen DJ;
    Circulation; 2011 Nov; 124(18):1964-72. PubMed ID: 21969017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy.
    Gada H; Kirtane AJ; Wang K; Lei Y; Magnuson E; Reynolds MR; Williams MR; Kodali S; Vahl TP; Arnold SV; Leon MB; Thourani V; Szeto WY; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):338-46. PubMed ID: 26058718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis.
    Chetcuti SJ; Deeb GM; Popma JJ; Yakubov SJ; Grossman PM; Patel HJ; Casale A; Dauerman HL; Resar JR; Boulware MJ; Dries-Devlin JL; Li S; Oh JK; Reardon MJ
    JACC Cardiovasc Imaging; 2019 Jan; 12(1):67-80. PubMed ID: 30448116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of Paravalvular Aortic Regurgitation and Remodeling of Self-Expanding Transcatheter Aortic Valve: An Observation From the CoreValve U.S. Pivotal Trial.
    Oh JK; Little SH; Abdelmoneim SS; Reardon MJ; Kleiman NS; Lin G; Bach D; Gillam L; Kar B; Coselli J; Sengupta PP; Grewal K; Chang J; Chang Y; Boulware M; Adams DH; Popma JJ;
    JACC Cardiovasc Imaging; 2015 Dec; 8(12):1364-1375. PubMed ID: 26508386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very Early Changes in Quality of Life After Transcatheter Aortic Valve Replacement: Results From the 3M TAVR Trial.
    Lauck SB; Arnold SV; Borregaard B; Sathananthan J; Humphries KH; Baron SJ; Wijeysundera HC; Asgar A; Welsh R; Velianou JL; Webb JG; Wood DA; Cohen DJ;
    Cardiovasc Revasc Med; 2020 Dec; 21(12):1573-1578. PubMed ID: 32571762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.
    Reynolds MR; Lei Y; Wang K; Chinnakondepalli K; Vilain KA; Magnuson EA; Galper BZ; Meduri CU; Arnold SV; Baron SJ; Reardon MJ; Adams DH; Popma JJ; Cohen DJ;
    J Am Coll Cardiol; 2016 Jan; 67(1):29-38. PubMed ID: 26764063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of frailty to outcomes after transcatheter aortic valve replacement (from the PARTNER trial).
    Green P; Arnold SV; Cohen DJ; Kirtane AJ; Kodali SK; Brown DL; Rihal CS; Xu K; Lei Y; Hawkey MC; Kim RJ; Alu MC; Leon MB; Mack MJ
    Am J Cardiol; 2015 Jul; 116(2):264-9. PubMed ID: 25963221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery.
    Yakubov SJ; Adams DH; Watson DR; Reardon MJ; Kleiman NS; Heimansohn D; Hermiller J; Hughes GC; Harrison JK; Coselli J; Diez J; Schreiber T; Gleason TG; Conte J; Deeb GM; Huang J; Oh J; Byrne T; Caskey M; Popma JJ;
    J Am Coll Cardiol; 2015 Sep; 66(12):1327-34. PubMed ID: 26383718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-Year Clinical and Quality of Life Outcomes From the CoreValve US Pivotal Extreme Risk Trial.
    Arnold SV; Petrossian G; Reardon MJ; Kleiman NS; Yakubov SJ; Wang K; Hermiller J; Harrison JK; Deeb GM; Huang J; Cohen DJ;
    Circ Cardiovasc Interv; 2021 Jun; 14(6):e010258. PubMed ID: 34092091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.